Health Care & Insurance

Indianapolis court backs patent for Lilly cancer drug Alimta

April 1, 2014
Associated Press
A federal court has upheld the patent that protects Eli Lilly and Co.'s lung-cancer treatment from generic competition until 2022.
More

Pence continues to seek repeal of medical device tax

March 31, 2014
 The Statehouse File
A number of Indiana lawmakers – including both of the state’s U.S. senators – have advocated for the elimination of the tax, in part because the state is home to several key medical device manufacturers.
More

Obamacare sign-ups on track to hit 7 million, sources say

March 31, 2014
Associated Press
The 7 million target, thought to be out of reach by most experts, was in sight on a day that saw surging consumer interest as well as vexing computer glitches.
More

Deadline brings crush of Indiana health coverage applicants

March 31, 2014
Associated Press
The last-minute flood of applicants in Indiana mirrored national trends as people sought to at least start the process Monday.
More

IU Health suffers small decline in 2013 profit

March 31, 2014
J.K. Wall
Indiana University Health’s business deteriorated last year in nearly every area. But price hikes and a surge in outpatient visits to Indianapolis-area facilities mostly offset those problems.
More

CNO Financial casts out former Conseco demonsRestricted Content

March 29, 2014
Chris O'Malley
It was an exorcism of CNO’s legacy Conseco business recently that’s really put the proverbial color back in the faces of management and investors.
More

Cancer treatment makes Endocyte premium takeover target

March 28, 2014
Bloomberg News
Now that Indiana-based Endocyte Inc.’s experimental cancer treatment is proving successful, the company may command a takeover bid at one of the industry’s highest premiums on record.
More

Would-be Lilly competitor's inhaled insulin tied to lung concerns

March 28, 2014
Bloomberg News
Afrezza, a powdered insulin used through an inhaler, would be the MannKind Corp.'s first marketed product. The treatment would compete against Lilly's Humalog. An FDA report tied the drug to a decline in lung function.
More

Obama says more than 6M signed up for health care

March 27, 2014
Associated Press
Like much else about Obama's health care law, the milestone comes with a caveat: The administration has yet to announce how many consumers actually closed the deal by paying their first month's premium.
More

Feds grant extra time to enroll for Obamacare

March 26, 2014
Associated Press
People who've started applying for health insurance but aren't able to finish before the March 31 enrollment deadline will get extra time, the Obama administration announced Tuesday.
More

Youth tanning measure signed into law by Pence

March 25, 2014
Associated Press
Minors under 16 no longer can hop into a tanning bed at Indiana salons, even with parental supervision.
More

WellPoint sees double-digit rate rise for Obamacare in 2015

March 25, 2014
Bloomberg News
Two months before health insurers must submit rate proposals for 2015 to government regulators, WellPoint Inc. fired a surprising shot across their bow.
More

WellPoint shares top $100 on bullish 5-year forecast

March 24, 2014
J.K. Wall
The health insurer predicted growth in government-funded health insurance programs would push revenue above $100 billion by 2018. That prompted investors to push WellPoint stock above $100 per share—an all-time high for the company.
More

Lilly CEO got 10-percent pay boost last year

March 24, 2014
J.K. Wall
Lilly CEO John Lechleiter was paid $11.2 million in salary, bonus, stock and perks last year, according to Lilly's proxy statement filed Monday morning. That represented a 10-percent increase over his take in 2012.
More

Indiana braces for flood insurance subsidy changes

March 24, 2014
Associated Press
Thousands of Indiana homeowners who live in flood-prone neighborhoods are bracing for insurance premium increases, despite Congress' latest fix for the government's debt-saddled flood insurance program.
More

Bold developer stirs up nursing-home businessRestricted Content

March 22, 2014
J.K. Wall
Zeke Turner, the 36-year-old CEO of Mainstreet Property Group LLC—who frequently sports a boyish grin and a bold-colored dress shirt, but rarely dons a tie—said he’s “just getting started” in transforming the staid nursing home industry.
More

Endocyte stock doubles after key approval in Europe

March 21, 2014
Bloomberg News, J.K. Wall
The stock price of Endocyte Inc. skyrocketed by as much as 130 percent Friday morning after the drug company got a thumbs up in Europe to market its first drug and received a new round of favorable clinical trial results.
More

Lilly diabetes drug wins backing from EU regulator

March 21, 2014
Bloomberg News
Indianapolis-based Lilly is expected to garner $518 million in annual sales from Jardiance by 2019, according to the average of five analyst estimates compiled by Bloomberg.
More

WellPoint raises 2014 earnings forecast

March 21, 2014
Associated Press
WellPoint is already raising a 2014 earnings forecast it laid out earlier this year, but the nation's second-largest health insurer's projections are still below analyst expectations.
More

Discovery may be key to Alzheimer's treatment

March 20, 2014
Bloomberg News
Scientists have discovered that a gene-regulating protein that protects the developing brain of a fetus resurfaces in old age and may stave off dementia, a finding that could open a new path in Alzheimer’s research.
More

Obamacare shuffles market share in some states, report finds

March 18, 2014
Bloomberg News
A snapshot of Obamacare enrollment in seven states suggests the law hasn't significantly increased competition, but it has shuffled market share for some insurers, including Indianapolis-based WellPoint Inc.
More

Hurdles remain for Roche Diagnostics on HPV test

March 17, 2014
J.K. Wall
Roche could enjoy a huge increase in sales of its HPV tests if all doctors and women followed a recommendation issued last week by an advisory committee at the FDA. But wrinkles in the U.S. health care system still present several big obstacles.
More

WellPoint getting unexpected competition from co-ops

March 13, 2014
Bloomberg News
Obamacare opponents predicted early on that insurance co-ops created by the law would fail, but several are doing well by combining low premiums with a certain homespun appeal.
More

Lawmakers getting closer on nursing home moratorium

March 11, 2014
Associated Press
House Public Health Chairman Ed Clere said Tuesday that negotiators had found a compromise that would ban new construction for two years except in counties whose nursing homes are at 90-percent capacity or higher.
More

Federal insurance enrollment up 36 percent in Indiana

March 11, 2014
Associated Press
Nearly 65,000 Indiana residents have signed up for private insurance under the federal health care law, but the number is still far short of initial projections as the open enrollment deadline nears.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. The $104K to CRC would go toward debts service on $486M of existing debt they already have from other things outside this project. Keystone buys the bonds for 3.8M from CRC, and CRC in turn pays for the parking and site work, and some time later CRC buys them back (with interest) from the projected annual property tax revenue from the entire TIF district (est. $415K / yr. from just this property, plus more from all the other property in the TIF district), which in theory would be about a 10-year term, give-or-take. CRC is basically betting on the future, that property values will increase, driving up the tax revenue to the limit of the annual increase cap on commercial property (I think that's 3%). It should be noted that Keystone can't print money (unlike the Federal Treasury) so commercial property tax can only come from consumers, in this case the apartment renters and consumers of the goods and services offered by the ground floor retailers, and employees in the form of lower non-mandatory compensation items, such as bonuses, benefits, 401K match, etc.

  2. $3B would hurt Lilly's bottom line if there were no insurance or Indemnity Agreement, but there is no way that large an award will be upheld on appeal. What's surprising is that the trial judge refused to reduce it. She must have thought there was evidence of a flagrant, unconscionable coverup and wanted to send a message.

  3. As a self-employed individual, I always saw outrageous price increases every year in a health insurance plan with preexisting condition costs -- something most employed groups never had to worry about. With spouse, I saw ALL Indiana "free market answer" plans' premiums raise 25%-45% each year.

  4. It's not who you chose to build it's how they build it. Architects and engineers decide how and what to use to build. builders just do the work. Architects & engineers still think the tarp over the escalators out at airport will hold for third time when it snows, ice storms.

  5. http://www.abcactionnews.com/news/duke-energy-customers-angry-about-money-for-nothing

ADVERTISEMENT